Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication related to notice for claiming shares from Unclaimed Suspense Account.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has published a notice in Business Standard newspaper about a shareholder's claim on shares held in the company's Unclaimed Suspense Account. Vijaykumar Madanlal Soni (jointly with Suruchi Vijaykumar Soni) has filed to claim 180 equity shares (Folio 0069079, Certificate 57621872–57622051) for transfer into their demat account. Any other person with a claim on these shares must submit details with supporting documents to the company's Registrar (MUFG Intime India) within 15 days of publication. If no competing claims arise, the company will transfer the shares to the claimant's demat account without further notice. This is a standard compliance filing under SEBI's Listing Regulations.
This is a routine procedural disclosure with no material impact on the company's financials, operations, or share price. It only affects one small lot of 180 shares and is part of normal regulatory housekeeping for unclaimed shares.